Status:
COMPLETED
Study of Treatment for Opioid Dependence and Anxiety Disorders
Lead Sponsor:
Mclean Hospital
Conditions:
Anxiety Disorders
Opiate Addiction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Anxiety is highly prevalent among individuals with opioid dependence and confers greater risk for continued opioid use and poor treatment outcomes. However, there are currently no efficacious treatmen...
Detailed Description
This Stage 1 behavioral treatment development trial involves two stages: manual development and pilot testing in an open trial, and a small randomized controlled trial. In both phases, opioid use and ...
Eligibility Criteria
Inclusion
- age 18 or older
- meet current Diagnostic and Statistical Manual of Mental Disorders 5th edition diagnostic criteria for opioid use disorder
- currently prescribed pharmacotherapy for opioid dependence
- have used opioids illicitly within the previous 90 days
- clinically-significant anxiety
- meet current diagnostic criteria for a Diagnostic and Statistical Manual of Mental Disorders 5th edition anxiety disorder
- able to read and provide informed consent
- intend to remain in the geographical area for the duration of the study period
Exclusion
- meet criteria for a current substance use or psychiatric disorder requiring a level of care higher than outpatient
- currently receiving cognitive behavioral therapy
- recent initiation of a psychiatric medication, defined as less than 4 weeks on a stable dose; not including PRN medications for sleep
- are receiving and taking an as-needed (PRN) prescription for benzodiazepines
- presence of a psychiatric or medical condition that would interfere with participation or that requires additional care (e.g. psychosis, acute suicidality)
- were admitted to McLean Hospital for their current treatment episode on an involuntary status
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT02252068
Start Date
January 1 2015
End Date
December 19 2019
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478